v3.25.4
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Total revenues $ 20,625 $ 19,672 $ 19,552
Gross profit 8,248 8,205 7,922
Selling, general, and administrative 4,225 4,269 4,282
Research and development 1,260 1,311 1,205
Total operating expenses 5,485 5,580 5,487
Operating income 2,763 2,625 2,435
Interest and other financial charges – net 440 504 542
Non-operating benefit (income) costs (288) (406) (382)
Other (income) expense – net (157) (55) (86)
Income from continuing operations before income taxes 2,768 2,581 2,361
Benefit (provision) for income taxes (614) (531) (743)
Net income from continuing operations 2,154 2,050 1,618
Income (loss) from discontinued operations, net of taxes 0 0 (4)
Net income 2,154 2,050 1,614
Net (income) loss attributable to noncontrolling interests (70) (57) (46)
Net income attributable to GE HealthCare 2,084 1,993 1,568
Deemed preferred stock dividend of redeemable noncontrolling interest 0 0 (183)
Net income attributable to GE HealthCare common stockholders $ 2,084 $ 1,993 $ 1,385
Earnings per share from continuing operations attributable to GE HealthCare common stockholders:      
Basic (in dollars per share) $ 4.56 $ 4.37 $ 3.06
Diluted (in dollars per share) 4.55 4.34 3.04
Earnings per share attributable to GE HealthCare common stockholders:      
Basic (in dollars per share) 4.56 4.37 3.05
Diluted (in dollars per share) $ 4.55 $ 4.34 $ 3.03
Weighted-average number of shares outstanding:      
Basic (in shares) 456 456 455
Diluted (in shares) 458 459 458
Product      
Total revenues $ 13,661 $ 13,075 $ 13,127
Cost of sales 8,942 8,271 8,465
Service      
Total revenues 6,964 6,597 6,425
Cost of sales $ 3,436 $ 3,196 $ 3,165